Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Pfuhlmann

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Pharmacopsychiatry|October 9, 2014
SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcomeF Proft, J Kopf, D Olmes, et al.
Pharmacopsychiatry|March 26, 2010
Serum concentrations, therapeutic response and side effects in children and adolescents with impulsive-aggressive symptoms during risperidone therapyK Klampfl, R Taurines, A Preuss, et al.
Pharmacopsychiatry|March 5, 2015
SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcomeF Proft, J Kopf, D Olmes, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|March 18, 2014
How to adjust media recommendations on reporting suicidal behavior to new media developmentsJ Maloney, B Pfuhlmann, E Arensman, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|August 30, 2001
[Somatotype-specific anthropometry and eating disorders]K J Neumärker, H Greil, A Brümmerhoff, et al.
Acta Psychiatrica Scandinavica|April 18, 2013
Media recommendations on reporting suicidal behaviour and suggestions for optimisationJ Maloney, B Pfuhlmann, E Arensman, et al.
Pharmacopsychiatry|October 5, 2011
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pharmacopsychiatry|November 5, 2011
AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pharmacopsychiatry|February 2, 2018
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017C Hiemke, N Bergemann, H W Clement, et al.
Pharmacopsychiatry|September 15, 2017
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017C Hiemke, N Bergemann, H W Clement, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Pharmacopsychiatry|October 9, 2014
SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcomeF Proft, J Kopf, D Olmes, et al.
Pharmacopsychiatry|March 26, 2010
Serum concentrations, therapeutic response and side effects in children and adolescents with impulsive-aggressive symptoms during risperidone therapyK Klampfl, R Taurines, A Preuss, et al.
Pharmacopsychiatry|March 5, 2015
SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcomeF Proft, J Kopf, D Olmes, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|March 18, 2014
How to adjust media recommendations on reporting suicidal behavior to new media developmentsJ Maloney, B Pfuhlmann, E Arensman, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|August 30, 2001
[Somatotype-specific anthropometry and eating disorders]K J Neumärker, H Greil, A Brümmerhoff, et al.
Acta Psychiatrica Scandinavica|April 18, 2013
Media recommendations on reporting suicidal behaviour and suggestions for optimisationJ Maloney, B Pfuhlmann, E Arensman, et al.
Pharmacopsychiatry|October 5, 2011
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pharmacopsychiatry|November 5, 2011
AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pharmacopsychiatry|February 2, 2018
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017C Hiemke, N Bergemann, H W Clement, et al.
Pharmacopsychiatry|September 15, 2017
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017C Hiemke, N Bergemann, H W Clement, et al.
Pageof 5